Efficacy and feasibility of sorafenib as a maintenance agent after allogeneic hematopoietic stem cell transplantation for Fms-like tyrosine kinase 3-mutated acute myeloid leukemia
Origin | Files produced by the author(s) |
---|
Origin | Files produced by the author(s) |
---|
Accord Elsevier CCSD : Connect in order to contact the contributor
https://hal.univ-lorraine.fr/hal-01777827
Submitted on : Monday, October 25, 2021-4:30:37 PM
Last modification on : Tuesday, June 25, 2024-11:35:10 AM
Long-term archiving on : Wednesday, January 26, 2022-9:41:35 PM